Income Statement EssilorLuxottica
Equities
EL
FR0000121667
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 173.25 EUR | +0.03% |
|
+1.08% | -35.81% |
| 15/05 | Less is more: Marc Jacobs sale shows LVMH cutting complexity as downturn drags on | RE |
| 14/05 | MPS-Mediobanca Takeover: Nattino's PC and Phone Seized | AN |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 1.98TCr | 2.45TCr | 2.54TCr | 2.65TCr | 2.85TCr | |||||
Total Revenues | 1.98TCr | 2.45TCr | 2.54TCr | 2.65TCr | 2.85TCr | |||||
Cost of Goods Sold, Total | 771Cr | 912Cr | 956.1Cr | 993.4Cr | 1.15TCr | |||||
Gross Profit | 1.21TCr | 1.54TCr | 1.58TCr | 1.66TCr | 1.7TCr | |||||
Selling General & Admin Expenses, Total | 903Cr | 1.16TCr | 1.2TCr | 1.25TCr | 1.29TCr | |||||
Stock-Based Compensation (IS) | - | - | - | - | - | |||||
R&D Expenses | 58Cr | 60Cr | 59Cr | 63Cr | 66Cr | |||||
Other Operating Expenses | -50L | -60L | -2.1Cr | -50L | -2.2Cr | |||||
Other Operating Expenses, Total | 960.4Cr | 1.21TCr | 1.26TCr | 1.31TCr | 1.35TCr | |||||
Operating Income | 250.6Cr | 323Cr | 326.3Cr | 348.1Cr | 347.3Cr | |||||
Interest Expense, Total | -14Cr | -16Cr | -20Cr | -25Cr | -31Cr | |||||
Interest And Investment Income | 3Cr | 3Cr | 8.7Cr | 9.7Cr | 9.6Cr | |||||
Net Interest Expenses | -11Cr | -13Cr | -11Cr | -16Cr | -22Cr | |||||
Income (Loss) On Equity Invest. | 30L | 60L | -10L | 30L | - | |||||
Currency Exchange Gains (Loss) | -1.1Cr | 1.2Cr | -70L | 2Cr | 6.9Cr | |||||
Other Non Operating Income (Expenses) | -70L | -1.9Cr | -2.3Cr | -2.4Cr | -3.6Cr | |||||
EBT, Excl. Unusual Items | 238Cr | 310.3Cr | 312.1Cr | 332.4Cr | 328.8Cr | |||||
Restructuring Charges | -9.6Cr | -6.7Cr | -9.6Cr | -5.2Cr | -6.3Cr | |||||
Merger & Related Restructuring Charges | -6.5Cr | -1.1Cr | - | -1.3Cr | -1.2Cr | |||||
Gain (Loss) On Sale Of Investments | - | 4.1Cr | 1.2Cr | - | - | |||||
Gain (Loss) On Sale Of Assets | -20L | 90L | -20L | - | -30L | |||||
Asset Writedown | -5.1Cr | -2.4Cr | - | - | - | |||||
Legal Settlements | - | - | - | -1Cr | -1.5Cr | |||||
Other Unusual Items | 3.4Cr | -2Cr | - | 4.2Cr | - | |||||
EBT, Incl. Unusual Items | 220Cr | 303.1Cr | 303.5Cr | 329.1Cr | 319.5Cr | |||||
Income Tax Expense | 59Cr | 75Cr | 61Cr | 80Cr | 75Cr | |||||
Earnings From Continuing Operations | 161.3Cr | 228Cr | 242.6Cr | 249.1Cr | 244.3Cr | |||||
Net Income to Company | 161.3Cr | 228Cr | 242.6Cr | 249.1Cr | 244.3Cr | |||||
Minority Interest | -15Cr | -13Cr | -14Cr | -13Cr | -13Cr | |||||
Net Income - (IS) | 146.3Cr | 215.2Cr | 228.9Cr | 235.9Cr | 231.5Cr | |||||
Net Income to Common Incl Extra Items | 146.3Cr | 215.2Cr | 228.9Cr | 235.9Cr | 231.5Cr | |||||
Net Income to Common Excl. Extra Items | 146.3Cr | 215.2Cr | 228.9Cr | 235.9Cr | 231.5Cr | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 3.33 | 4.87 | 5.11 | 5.2 | 5.04 | |||||
Basic EPS - Continuing Operations | 3.33 | 4.87 | 5.11 | 5.2 | 5.04 | |||||
Basic Weighted Average Shares Outstanding | 44Cr | 44Cr | 45Cr | 45Cr | 46Cr | |||||
Net EPS - Diluted | 3.28 | 4.83 | 5.08 | 5.13 | 4.98 | |||||
Diluted EPS - Continuing Operations | 3.28 | 4.83 | 5.08 | 5.13 | 4.98 | |||||
Diluted Weighted Average Shares Outstanding | 45Cr | 45Cr | 45Cr | 46Cr | 46Cr | |||||
Normalized Basic EPS | 3.05 | 4.1 | 4.05 | 4.29 | 4.2 | |||||
Normalized Diluted EPS | 3 | 4.06 | 4.02 | 4.23 | 4.15 | |||||
Dividend Per Share | 2.51 | 3.23 | 3.95 | 3.95 | 4 | |||||
Payout Ratio | 9.43 | 21.1 | 21.28 | 49.3 | 23.63 | |||||
American Depositary Receipts Ratio (ADR) | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | |||||
Supplemental Items | ||||||||||
EBITDA | 420.3Cr | 522.7Cr | 528.1Cr | 556.2Cr | 557Cr | |||||
EBITA | 359.2Cr | 453.2Cr | 456.7Cr | 478.1Cr | 473.3Cr | |||||
EBIT | 250.6Cr | 323Cr | 326.3Cr | 348.1Cr | 347.3Cr | |||||
EBITDAR | 460.6Cr | 578.2Cr | 585.3Cr | 614Cr | 617Cr | |||||
Effective Tax Rate - (Ratio) | 26.68 | 24.78 | 20.07 | 24.31 | 23.54 | |||||
Total Current Taxes | 78Cr | 90Cr | 81Cr | 100.6Cr | 90Cr | |||||
Total Deferred Taxes | -20Cr | -15Cr | -20Cr | -21Cr | -15Cr | |||||
Normalized Net Income | 133.75Cr | 181.14Cr | 181.36Cr | 194.55Cr | 192.7Cr | |||||
Interest on Long-Term Debt | 5.2Cr | 6.9Cr | 9Cr | 11Cr | 13Cr | |||||
Non-Cash Pension Expense | -2Cr | 60L | 1.1Cr | 1.1Cr | 1.7Cr | |||||
Supplemental Operating Expense Items | ||||||||||
Advertising Expense | 146.2Cr | 178.7Cr | 179.9Cr | 182Cr | 183.6Cr | |||||
Selling and Marketing Expenses | 716.2Cr | 950.4Cr | 984Cr | 1.03TCr | 1.06TCr | |||||
General and Administrative Expenses | 186.8Cr | 204.6Cr | 215.9Cr | 212.9Cr | 228.5Cr | |||||
Research And Development Expense From Footnotes | 85Cr | 87Cr | 87Cr | 90Cr | 92Cr | |||||
Net Rental Expense, Total | 40Cr | 56Cr | 57Cr | 58Cr | 60Cr | |||||
Imputed Operating Lease Interest Expense | 3.65Cr | 5.49Cr | 7.59Cr | 9.41Cr | 11Cr | |||||
Imputed Operating Lease Depreciation | 37Cr | 50Cr | 50Cr | 48Cr | 49Cr | |||||
Stock-Based Comp., COGS (Total) | 20L | - | - | - | 7Cr | |||||
Stock-Based Comp., S&M Exp. (Total) | 10L | - | - | - | - | |||||
Stock-Based Comp., G&A Exp. (Total) | 50L | - | - | - | - | |||||
Stock-Based Comp., Other (Total) | 20Cr | 21Cr | 22Cr | 21Cr | 28Cr | |||||
Total Stock-Based Compensation | 21Cr | 21Cr | 22Cr | 21Cr | 36Cr |
- Stock Market
- Equities
- EL Stock
- Financials EssilorLuxottica
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















